8-(4-(1-((1-Methyl-1H-pyrazol-4-yl)methyl)piperidin-4-yl)-1H-pyrazol-1-yl)pyrido[3,4-d]pyrimidin-4(3H)-one

ID: ALA4483792

PubChem CID: 155540572

Max Phase: Preclinical

Molecular Formula: C20H22N8O

Molecular Weight: 390.45

Molecule Type: Unknown

Names and Identifiers

Canonical SMILES:  Cn1cc(CN2CCC(c3cnn(-c4nccc5c(=O)[nH]cnc45)c3)CC2)cn1

Standard InChI:  InChI=1S/C20H22N8O/c1-26-10-14(8-24-26)11-27-6-3-15(4-7-27)16-9-25-28(12-16)19-18-17(2-5-21-19)20(29)23-13-22-18/h2,5,8-10,12-13,15H,3-4,6-7,11H2,1H3,(H,22,23,29)

Standard InChI Key:  JJUBVVYZQHPFMF-UHFFFAOYSA-N

Molfile:  

 
     RDKit          2D

 29 33  0  0  0  0  0  0  0  0999 V2000
   17.9892  -13.4052    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.9880  -14.2247    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   18.6961  -14.6337    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.6943  -12.9963    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.4029  -13.4016    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.4037  -14.2206    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.1122  -14.6277    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   20.8205  -14.2169    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.8157  -13.3947    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   20.1066  -12.9914    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.6985  -15.4485    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   18.0385  -15.9304    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   18.2928  -16.7070    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.1101  -16.7051    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.3607  -15.9273    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.1023  -12.1742    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   19.5969  -17.3651    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.2641  -18.1125    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.7424  -18.7707    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.5557  -18.6875    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   20.8884  -17.9401    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.4079  -17.2759    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.0351  -19.3493    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.7017  -20.0954    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.9069  -20.2677    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.8204  -21.0803    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   20.5665  -21.4137    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   21.1141  -20.8071    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.1121  -21.4879    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  2  3  1  0
  3  6  2  0
  5  4  2  0
  4  1  1  0
  5  6  1  0
  6  7  1  0
  7  8  2  0
  8  9  1  0
  9 10  1  0
 10  5  1  0
 11 12  1  0
 12 13  2  0
 13 14  1  0
 14 15  2  0
 15 11  1  0
  3 11  1  0
 10 16  2  0
 17 18  1  0
 17 22  1  0
 18 19  1  0
 19 20  1  0
 20 21  1  0
 21 22  1  0
 14 17  1  0
 20 23  1  0
 23 24  1  0
 24 25  2  0
 25 26  1  0
 26 27  1  0
 27 28  2  0
 28 24  1  0
 26 29  1  0
M  END

Alternative Forms

1. Parent:

   

   ALA4483792

   ---

Molecule Features

Natural Product: No

Oral: No

Chemical Probe: No

Parenteral: No

Molecule Type: Unknown

Topical: No

First In Class: No

Black Box: No

Chirality: No

Availability: No

Prodrug: No

Calculated Properties

Molecular Weight: 390.45

Molecular Weight (Monoisotopic): 390.1917

AlogP: 1.62

#Rotatable Bonds: 4

Polar Surface Area: 97.52

Molecular Species: NEUTRAL

HBA: 8

HBD: 1

#RO5 Violations: ┄

HBA (Lipinski): 9

HBD (Lipinski): 1

#RO5 Violations (Lipinski): ┄

CX Acidic pKa: 10.03

CX Basic pKa: 7.86

CX LogP: 0.83

CX LogD: 0.24

Aromatic Rings: 4

Heavy Atoms: 29

QED Weighted: 0.57

Np Likeness Score: -1.58

References

1. Le Bihan YV, Lanigan RM, Atrash B, McLaughlin MG, Velupillai S, Malcolm AG, England KS, Ruda GF, Mok NY, Tumber A, Tomlin K, Saville H, Shehu E, McAndrew C, Carmichael L, Bennett JM, Jeganathan F, Eve P, Donovan A, Hayes A, Wood F, Raynaud FI, Fedorov O, Brennan PE, Burke R, van Montfort RLM, Rossanese OW, Blagg J, Bavetsias V..  (2019)  C8-substituted pyrido[3,4-d]pyrimidin-4(3H)-ones: Studies towards the identification of potent, cell penetrant Jumonji C domain containing histone lysine demethylase 4 subfamily (KDM4) inhibitors, compound profiling in cell-based target engagement assays.,  177  [PMID:31158747] [10.1016/j.ejmech.2019.05.041]

Source

Source(1):

• Scientific Literature